Rallybio Corp (RLYB): Nasdaq/NYSE listing notice — Rallybio receives Nasdaq bid price deficiency notice; faces potential delisting

Rallybio Corp

Notice on Feb 24, 2025: closing bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until August 25, 2025, to regain compliance by closing at $1.00+ for 10 days.
If not cured, may qualify for additional 180-day period by transferring to Nasdaq Capital Market.
Failure to regain compliance could lead to delisting and potential appeal to Nasdaq Hearings Panel.
No immediate impact on trading; stock continues to list on Nasdaq under other requirements.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Rallybio Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

February 24, 2025, Rallybio Corporation (the “Company” or “Rallybio”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the last 30 consecutive business days (the “Notice”), as required for continued listing on the Nasdaq under Rule 5450(a)(1) of the Nasdaq’s Listing Rules (the “Rules”). The Notice has no immediate impact on the listing of the Company’s common stock, wh

View on SEC.gov

Browse all listing & compliance notices →

Rallybio Corp filing history →

Source: SEC EDGAR

accession 0001739410-25-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.